Where are we in the management of type 2 DM?

Mohamed Hassan Hatahet
{"title":"Where are we in the management of type 2 DM?","authors":"Mohamed Hassan Hatahet","doi":"10.15406/jdmdc.2019.06.00176","DOIUrl":null,"url":null,"abstract":"Efficacy a) Oral medications tend to be less effective in lowering HbA1c (< 1% reduction). b) Insulin and GLP1 RA reduce HbA1c more, alone or in combination. c) Basal insulin and GLP1 RA are similar in reducing HbA1c when used as 1st injectable. d) Adding an oral medication looks reasonable when HbA1c is still between 7-8%. e) Adding one of the injectable when HbA1c is 8% or above is the most reasonable to a patient on oral medication. f) Adding two or more oral medications can bring high HbA1c to goal.","PeriodicalId":92240,"journal":{"name":"Journal of diabetes, metabolic disorders & control","volume":"64 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of diabetes, metabolic disorders & control","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jdmdc.2019.06.00176","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Efficacy a) Oral medications tend to be less effective in lowering HbA1c (< 1% reduction). b) Insulin and GLP1 RA reduce HbA1c more, alone or in combination. c) Basal insulin and GLP1 RA are similar in reducing HbA1c when used as 1st injectable. d) Adding an oral medication looks reasonable when HbA1c is still between 7-8%. e) Adding one of the injectable when HbA1c is 8% or above is the most reasonable to a patient on oral medication. f) Adding two or more oral medications can bring high HbA1c to goal.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2型糖尿病的治疗进展如何?
a)口服药物降低HbA1c的效果较差(< 1%)。b)胰岛素和GLP1 RA单独或联合使用更能降低HbA1c。c)第一次注射时,基础胰岛素和GLP1 RA在降低HbA1c方面相似。d)当HbA1c仍在7-8%之间时,添加口服药物似乎是合理的。e)口服用药患者在HbA1c为8%及以上时加用其中一种注射剂最为合理。f)加用两种或两种以上口服药物可使高HbA1c达到目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
COVID-19 with pulmonary tuberculosis with unilateral hydropneumothorax: case report from a primary care center in Bangladesh Impact of different exercise training on mitochondrial in diabetic nephropathy Integrating microvascular assessments into one clinic, in an annual one-stop approach Improvement in cardiovascular and renal outcomes in type 2 diabetes: effect of glycemic control, not drugs Exercise and brain function in obese & overweight people - a review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1